Competition_NN between_IN the_DT Sendai_NP Virus_NP N_NP mRNA_NP Start_NP Site_NP and_CC the_DT Genome_NP 3'-End_JJ Promoter_NN for_IN Viral_NP RNA_NP Polymerase_NP The_DT genomic_JJ and_CC antigenomic_JJ 3'-end_JJ replication_NN promoters_NNS of_IN Sendai_NP virus_NN are_VBP bipartite_JJ in_IN nature_NN and_CC symmetrical_JJ ,_, composed_VBN of_IN le_FW or_CC tr_NN sequences_NNS ;_: a_DT gene_NN start_NN or_CC gene_NN end_NN site_NN ,_, respectively_RB ;_: and_CC a_DT simple_JJ hexameric_JJ repeat_NN ._SENT The_DT relative_JJ strengths_NNS of_IN these_DT 3'-end_JJ promoters_NNS determines_VBZ the_DT ratios_NNS of_IN genomes_NNS and_CC antigenomes_NNS formed_VBN during_IN infection_NN and_CC whether_IN model_NN mini-genomes_NNS can_MD be_VB rescued_VBN from_IN DNA_NN by_IN nondefective_JJ helper_NN viruses_NNS ._SENT Using_VBG these_DT tests_NNS of_IN promoter_NN strength_NN ,_, we_PP have_VBP confirmed_VBN that_IN tr_NN is_VBZ stronger_JJR than_IN le_DT in_IN this_DT respect_NN ._SENT We_PP have_VBP also_RB found_VBN that_IN the_DT presence_NN of_IN a_DT gene_NN start_NN site_NN within_IN either_DT 3'-end_JJ promoter_NN strongly_RB reduces_VBZ 3'-end_JJ promoter_NN strength_NN ._SENT The_DT negative_JJ effects_NNS of_IN the_DT gene_NN start_NN site_NN on_IN the_DT 3'-end_JJ promoter_NN suggest_VBP that_IN these_DT closely_RB spaced_VBN RNA_NP start_NN sites_NNS compete_VBP with_IN each_DT other_JJ for_IN a_DT common_JJ pool_NN of_IN viral_JJ RNA_NP polymerase_NN ._SENT The_DT manner_NN in_IN which_WDT this_DT competition_NN could_MD occur_VB for_IN polymerase_NN off_IN the_DT template_NN (_( in_IN trans_NNS )_) and_CC polymerase_NN on_IN the_DT template_NN (_( in_IN cis_NN )_) adds_VBZ insight_NN into_IN how_WRB the_DT viral_JJ RNA_NP polymerase_NN switches_NNS between_IN its_PP$ dual_JJ functions_NNS as_IN transcriptase_NN and_CC replicase_NN ._SENT Sendai_NP virus_NN (_( SeV_NP )_) ,_, a_DT Respirovirus_NP of_IN the_DT Paramyxovirinae_NP subfamily_NN ,_, is_VBZ a_DT model_JJ nonsegmented_JJ negative-strand_NN RNA_NP virus_NN ._SENT The_DT first_JJ step_NN in_IN the_DT SeV_NP replication_NN cycle_NN is_VBZ the_DT production_NN of_IN mRNA_NN from_IN a_DT helical_JJ subviral_JJ structure_NN ,_, the_DT nucleocapsid_NN (_( NC_NP )_) ,_, in_IN which_WDT the_DT genome_NN RNA_NP is_VBZ tightly_RB and_CC stoichiometrically_RB associated_VBN with_IN the_DT viral_JJ NC_NP protein_NN (_( N_NP protein_NN )_) ._SENT This_DT N-subunit_NP assembly_NN ,_, together_RB with_IN multiple_JJ attached_VBN viral_JJ polymerases_NNS (_( a_DT complex_NN of_IN the_DT P_NN and_CC L_NN proteins_NNS )_) is_VBZ the_DT minimum_JJ subviral_JJ unit_NN that_WDT is_VBZ thought_VBN to_TO retain_VB infectivity_NN ._SENT The_DT synthesis_NN of_IN RNA_NP genomes_NNS (_( or_CC [_SYM +_SYM ]_SYM antigenomes_NNS )_) and_CC their_PP$ assembly_NN with_IN N_NP protein_NN is_VBZ coupled_VBN ,_, and_CC these_DT viral_JJ RNAs_NP are_VBP only_RB found_VBN as_IN nucleocapsids_NNS ._SENT Electron_NP micrographs_NNS of_IN SeV_NP nucleocapsids_NNS show_VBP a_DT flexible_JJ helical_JJ assembly_NN with_IN 13_CD N_NP subunits_NN per_IN turn_NN and_CC variable_JJ pitch_NN ,_, in_IN which_WDT each_DT N_NP subunit_NN binds_VBZ 6_CD nucleotides_NNS (_( nt_NN )_) ._SENT For_IN viruses_NNS of_IN the_DT Paramyxovirinae_NP ,_, efficient_JJ replication_NN of_IN model_NN mini-genomes_NNS in_IN transfected_JJ cells_NNS requires_VBZ that_IN their_PP$ total_JJ length_NN be_VB a_DT multiple_NN of_IN six_CD ,_, and_CC viruses_NNS of_IN this_DT group_NN whose_WP$ genome_NN has_VBZ been_VBN entirely_RB sequenced_JJ mostly_RB have_VB genome_NN lengths_NNS that_WDT are_VBP multiples_NNS of_IN six_CD ._SENT Inefficient_JJ replication_NN of_IN non-hexamer-length_JJ mini-genomes_NNS was_VBD not_RB due_JJ to_TO the_DT lack_NN of_IN encapsidation_NN of_IN the_DT mini-genome_NN but_CC apparently_RB was_VBD due_JJ to_TO the_DT inability_NN of_IN viral_JJ RNA-dependent_NP RNA_NP polymerase_NN (_( vRdRP_NP )_) to_TO initiate_VB at_IN the_DT mini-nucleocapsid_JJ 3_CD '_POS end_NN ._SENT It_PP has_VBZ been_VBN suggested_VBN that_IN nucleocapsid_JJ assembly_NN begins_VBZ with_IN the_DT first_JJ 6_CD nt_NNS at_IN the_DT 5_CD '_POS end_NN of_IN the_DT nascent_JJ chain_NN and_CC continues_VBZ by_IN assembling_VBG 6_CD nt_NN at_IN a_DT time_NN until_IN the_DT 3_CD '_POS end_NN is_VBZ reached_VBN ._SENT The_DT efficiency_NN of_IN the_DT 3'-end_JJ promoter_NN then_RB presumably_RB depends_VBZ on_IN the_DT position_NN of_IN these_DT cis-acting_JJ sequences_NNS relative_JJ to_TO the_DT N_NP subunits_NN ,_, and_CC this_DT hexamer_NN or_CC N-subunit_JJ "_`` phase_NN "_'' is_VBZ determined_VBN by_IN the_DT precise_JJ length_NN of_IN the_DT genome_NN chain_NN ._SENT The_DT requirement_NN for_IN hexameric_JJ genome_NN length_NN of_IN the_DT Paramyxovirinae_NP has_VBZ recently_RB been_VBN underscored_VBN for_IN human_JJ parainfluenza_NN virus_NN type_NN 2_CD (_( hPIV2_NN )_) ,_, a_DT rubulavirus_NN ,_, and_CC measles_NN virus_NN ,_, a_DT morbillivirus_NN ._SENT hPIV2_NN recovered_VBD from_IN non-hexameric-length_JJ cDNAs_NNS were_VBD found_VBN to_TO contain_VB a_DT biased_VBN distribution_NN of_IN mutations_NNS that_IN all_DT restored_VBN hexameric_JJ genome_NN length_NN ._SENT Similarly_RB ,_, an_DT obligatorily_RB diploid_JJ measles_NN virus_NN was_VBD recovered_VBN from_IN DNA_NP that_WDT encodes_VBZ a_DT defective_JJ H_NN protein_NN ,_, again_RB via_IN mutations_NNS that_WDT restore_VBP hexameric_JJ genome_NN length_NN ._SENT The_DT genomic_JJ and_CC antigenomic_JJ promoters_NNS (_( G/Pr_NP and_CC AG/Pr_NP )_) of_IN the_DT Paramyxovirinae_NNS are_VBP found_VBN within_IN the_DT terminal_JJ 96_CD nt_NNS or_CC 16_CD N_NN subunits_NN of_IN each_DT RNA_NP and_CC are_VBP composed_VBN of_IN leader_NN (_( le_FW )_) or_CC trailer_NN (_( tr_NN )_) sequences_NNS ;_: a_DT gene_NN start_NN or_CC gene_NN end_NN site_NN ,_, respectively_RB ;_: and_CC a_DT simple_JJ hexameric_JJ repeat_NN (_( Fig._NN ;_: see_VB also_RB Fig._NN )_) ._SENT Although_IN G/Pr_NP and_CC AG/Pr_NP are_VBP similar_JJ in_IN overall_JJ structure_NN ,_, they_PP carry_VBP out_RP separate_JJ functions_NNS ._SENT G/Pr_NP is_VBZ associated_VBN with_IN le_DT RNA_NP ,_, antigenome_NP RNA_NP ,_, and_CC mRNA_NN synthesis_NN ,_, while_IN AG/Pr_NP is_VBZ associated_VBN with_IN tr_NP RNA_NP and_CC genome_NN RNA_NP synthesis_NN ._SENT The_DT relative_JJ abundance_NN of_IN the_DT various_JJ viral_JJ RNAs_NP throughout_IN the_DT infection_NN is_VBZ regulated_VBN in_IN large_JJ part_NN via_IN G/Pr_NP and_CC AG/Pr_NP ,_, and_CC this_DT ensures_VBZ as_RB well_RB that_IN a_DT preponderance_NN of_IN genomes_NNS are_VBP produced_VBN during_IN infection_NN ._SENT These_DT 3'-end_JJ promoters_NNS are_VBP (_( at_IN least_JJS )_) bipartite_JJ in_IN nature_NN ._SENT There_EX is_VBZ both_CC an_DT end_NN element_NN comprising_VBG ca_MD ._SENT the_DT first_JJ 30_CD nt_NNS at_IN the_DT 3_CD '_POS ends_NNS (_( in_IN which_WDT the_DT first_JJ 12_CD nt_NNS are_VBP conserved_VBN between_IN G/Pr_NP and_CC AG/Pr_NP and_CC across_IN each_DT genus_NN )_) ,_, and_CC a_DT downstream_JJ element_NN within_IN the_DT 5_CD '_POS untranslated_JJ region_NN of_IN the_DT N_NP gene_NN (_( nucleocapsids_NNS )_) or_CC the_DT 3_CD '_POS untranslated_JJ region_NN of_IN the_DT L_NP gene_NN (_( [_SYM +_SYM ]_SYM nucleocapsids_NNS )_) ._SENT For_IN SeV_NP and_CC hPIV3_JJ and_CC apparently_RB all_DT respiro-_NN and_CC morbilliviruses_NNS ,_, the_DT downstream_JJ element_NN is_VBZ a_DT simple_JJ but_CC phased_VBN hexameric_JJ repeat_NN (_( 3_CD '_'' [_SYM C1N2N3N4N5N6]3_NP ,_, bound_VBN to_TO the_DT 14th_JJ ,_, 15th_JJ ,_, and_CC 16th_JJ N_NP protein_NN subunits_NN [_SYM ,_, ]_SYM )_) ._SENT For_IN rubulaviruses_NNS like_IN SV5_NP ,_, [_SYM N1N2N3N4G5C6]3_NN is_VBZ repeated_VBN in_IN subunits_NN 13_CD ,_, 14_CD ,_, and_CC 15_CD ,_, such_JJ that_IN all_PDT these_DT conserved_VBN nucleotides_NNS are_VBP adjacent_JJ to_TO the_DT first_JJ 12_CD nt_NNS in_IN the_DT helical_JJ nucleocapsid_NN with_IN 13_CD subunits_NN per_IN turn_NN ._SENT This_DT common_JJ surface_NN ,_, comprising_VBG the_DT conserved_VBN sequences_NNS of_IN both_DT elements_NNS of_IN the_DT bipartite_JJ promoter_NN on_IN two_CD turns_NNS of_IN the_DT helix_NN ,_, is_VBZ thought_VBN to_TO mediate_VB the_DT initial_JJ interaction_NN of_IN vRdRP_NP with_IN resting_VBG nucleocapsids_NNS to_TO initiate_VB RNA_NP synthesis_NN at_IN the_DT genome_NN 3_CD '_'' end_NN (_( see_VB below_IN )_) ._SENT The_DT remarkable_JJ sequence_NN simplicity_NN of_IN the_DT downstream_JJ promoter_NN element_NN is_VBZ presumably_RB possible_JJ because_IN its_PP$ hexamer_NN phase_NN also_RB contributes_VBZ to_TO its_PP$ activity_NN ._SENT This_DT phase_NN effect_NN is_VBZ thought_VBN to_TO stem_VB from_IN the_DT different_JJ chemical_NN environments_NNS of_IN the_DT 6_CD nt_NN bases_NNS associated_VBN with_IN each_DT N_NP subunit_NN ,_, as_RB revealed_VBN by_IN chemical_JJ attack_NN studies_NNS of_IN resting_JJ SeV_NP nucleocapsids_NNS ._SENT Adenosines_NNS in_IN any_DT hexamer_NN phase_NN are_VBP largely_RB protected_VBN from_IN dimethyl_NN sulfate_NN ,_, whereas_IN cytosine_NN reactivity_NN is_VBZ highly_RB variable_JJ and_CC strongly_RB depends_VBZ on_IN hexamer_NN phase_NN ._SENT Cytosines_NNS are_VBP highly_RB reactive_JJ only_RB in_IN hexamer_NN positions_NNS 1_CD and_CC 6_CD ,_, precisely_RB the_DT positions_NNS of_IN the_DT conserved_VBN cytosines_NNS in_IN the_DT downstream_JJ element_NN of_IN G/Pr_NP and_CC AG/Pr_NP ._SENT If_IN this_DT correlation_NN is_VBZ not_RB coincidental_JJ ,_, this_DT suggests_VBZ that_IN the_DT conservation_NN of_IN hexamer_NN phase_NN of_IN this_DT cis-acting_JJ sequence_NN serves_VBZ to_TO make_VB these_DT cytosines_NNS accessible_JJ to_TO vRdRP_NP in_IN resting_VBG NCs_NP ._SENT Another_DT feature_NN strictly_RB conserved_VBN among_IN respiro-_NN ,_, morbilli-_NN ,_, and_CC rubulaviruses_NNS is_VBZ that_IN the_DT first_JJ (_( N_NP )_) mRNA_NP starts_VBZ precisely_RB opposite_JJ U56_NP (_( underlined_VBN )_) within_IN the_DT decameric_JJ gene_NN start_NN signal_VBP 3_CD '_POS 55A/UCCCA_NP NUUUC/N66_NP (_( for_IN SeV_NP ,_, hexamer_NN phase_NN indicated_VBN )_) ._SENT We_PP refer_VBP to_TO this_DT mRNA_NN initiation_NN signal_NN as_IN gene_NN start_NN 1_CD (_( gs-1_NN )_) ._SENT Curiously_RB ,_, none_NN of_IN the_DT conserved_VBN cytosines_NNS of_IN gs-1_JJ are_VBP in_IN hexamer_NN positions_NNS 1_CD and_CC 6_CD ._SENT However_RB ,_, once_RB vRdRP_NP has_VBZ initiated_VBN RNA_NP synthesis_NN at_IN the_DT genome_NN 3_CD '_'' end_NN and_CC begun_VBN to_TO elongate_VB ,_, we_PP assume_VBP that_IN conformational_JJ changes_NNS occur_VBP within_IN N:RNA_NP that_WDT alter_VBP vRdRP_NP 's_POS interaction_NN with_IN the_DT nucleotide_NN bases_NNS ,_, including_VBG gs-1_JJ ._SENT Since_IN SeV_NP RdRP_NP is_VBZ minimally_RB a_DT coiled-coil_JJ tetramer_NN of_IN P_NN and_CC a_DT single_JJ L_NP protein_NN (_( with_IN an_DT aggregate_JJ molecular_JJ mass_NN equivalent_NN to_TO 8_CD N-subunits_NNS )_) and_CC this_DT polymerase_NN initiates_VBZ RNA_NP chains_NNS at_IN two_CD such_JJ closely_RB spaced_VBN sites_NNS at_IN the_DT genome_NN 3_CD '_'' end_NN (_( only_RB 56_CD nt_NNS apart_RB )_) ,_, one_PP would_MD expect_VB these_DT two_CD events_NNS to_TO interfere_VB with_IN each_DT other_JJ ,_, at_IN least_JJS under_IN some_DT conditions_NNS ._SENT However_RB ,_, detailed_JJ studies_NNS involving_VBG modified_JJ DI_NN mini-genomes_NNS did_VBD not_RB uncover_VB any_DT indication_NN that_IN gs-1_JJ affected_JJ G/Pr_NP strength_NN ;_: only_RB the_DT first_JJ 30_CD nt_NNS of_IN le/tr_NN regions_NNS were_VBD found_VBN to_TO influence_VB this_DT property_NN ._SENT We_PP now_RB report_VBP studies_NNS that_WDT show_VBP that_IN in_IN some_DT cases_NNS exactly_RB the_DT same_JJ situation_NN applies_VBZ ,_, namely_RB ,_, that_IN only_RB the_DT le/tr_NN sequences_NNS appear_VBP to_TO influence_VB promoter_NN strength_NN ._SENT More_RBR importantly_RB ,_, we_PP find_VBP other_JJ cases_NNS in_IN which_WDT gs-1_NN clearly_RB decreases_VBZ 3'-end_JJ promoter_NN strength_NN ._SENT The_DT manner_NN in_IN which_WDT gs-1_NN negatively_RB influences_VBZ G/Pr_NP strength_NN is_VBZ discussed_VBN ._SENT Generation_NN of_IN recombinant_JJ SeV_NP (_( rSeV_NP )_) ._SENT |_SYM Briefly_NP ,_, one_CD 9-cm-diameter_NN dish_NN of_IN BSR-T7_JJ cells_NNS that_WDT endogenously_RB express_VBP T7_JJ RNA_NP polymerase_NN were_VBD transfected_VBN with_IN 1.5_CD mug_NN of_IN pGEM-L_NN ,_, 5_CD mug_NN of_IN pGEM-N_NN ,_, 5_CD mug_NN of_IN pGEM-PHA_NN (_( which_WDT does_VBZ not_RB express_VB C_NP proteins_NNS )_) ,_, and_CC 15_CD mug_NN of_IN the_DT various_JJ pSeV_NN infectious_JJ constructs_NNS ._SENT After_IN 24_CD h_NN the_DT cells_NNS were_VBD scraped_VBN into_IN their_PP$ medium_NN and_CC injected_VBD directly_RB into_IN the_DT allantoic_JJ cavity_NN of_IN 9-day-old_JJ embryonated_JJ chicken_NN eggs_NNS ._SENT Three_CD days_NNS later_RBR ,_, the_DT allantoic_JJ fluids_NNS were_VBD harvested_VBN and_CC reinjected_VBN undiluted_JJ into_IN eggs_NNS ._SENT For_IN further_JJR passages_NNS ,_, the_DT viruses_NNS were_VBD diluted_VBN 1/500_CD before_IN injection_NN ._SENT The_DT presence_NN of_IN viruses_NNS was_VBD determined_VBN by_IN pelleting_VBG allantoic_JJ fluids_NNS through_IN a_DT TNE_NP (_( 10_CD mM_NP Tris-HCl_NP [_SYM pH_NN 8.0_CD ]_SYM ,_, 100_CD mM_NP NaCl_NP ,_, 1_CD mM_NP EDTA)-25_NP %_NN glycerol_NN cushion_NN for_IN 20_CD min_NN at_IN 14,000_CD rpm_NN in_IN an_DT Eppendorf_NP 5417C_NN centrifuge_NN ._SENT Virus_NN pellets_NNS were_VBD resuspended_VBN in_IN sample_NN buffer_NN ,_, and_CC the_DT proteins_NNS were_VBD separated_VBN by_IN sodium_NN dodecyl_NN sulfate-10_NN %_NN polyacrylamide_NN gel_NN electrophoresis_NN and_CC stained_VBN with_IN Coomassie_NP brilliant_JJ blue_NN ._SENT Virus_NN infection_NN and_CC passage_NN ._SENT |_SYM A549_NP or_CC BSR_NP T7_JJ cells_NNS were_VBD infected_VBN at_IN a_DT multiplicity_NN of_IN infection_NN (_( MOI_NP )_) of_IN 10_CD in_IN Dulbecco_NP 's_POS modified_JJ Eagle_NP medium_NN ._SENT After_IN 1_CD to_TO 2_CD h_NN of_IN absorption_NN ,_, the_DT inoculum_NN was_VBD removed_VBN and_CC replaced_VBN with_IN fresh_JJ medium_NN containing_VBG 10_CD %_NN fetal_JJ bovine_JJ serum_NN ._SENT Virus_NN supernatant_JJ from_IN 48-h-infected_JJ cells_NNS was_VBD cleared_VBN by_IN filtration_NN ,_, treated_VBN for_IN 1_CD h_NN with_IN trypsin_NN (_( 1.2_CD mug/ml_NN )_) ,_, and_CC used_VBN to_TO reinfect_NNS fresh_JJ A549_NP or_CC BSR_NP T7_JJ cells_NNS ._SENT Real-time_JJ PCR_NP ._SENT |_SYM A_DT 9-cm-diameter_NN dish_NN of_IN A549_NP cells_NNS was_VBD infected_VBN with_IN SeV_NP at_IN an_DT MOI_NP of_IN 10_CD ._SENT After_IN 24_CD h_NN ,_, medium_NN was_VBD removed_VBN ,_, the_DT cells_NNS were_VBD scraped_VBN ,_, and_CC total_JJ RNA_NP was_VBD extracted_VBN using_VBG Trizol_NP ._SENT One-tenth_NN of_IN this_DT RNA_NP was_VBD mixed_VBN with_IN 0.5_CD mug_NN of_IN specific_JJ primer_NN and_CC converted_VBN to_TO cDNA_NN with_IN Moloney_NP murine_JJ leukemia_NN virus_NN reverse_JJ transcriptase_NN for_IN 1_CD h_NN at_IN 37C_JJ ._SENT One-tenth_NN of_IN the_DT cDNA_NN was_VBD used_VBN for_IN real-time_JJ PCR_NP ,_, using_VBG TaqMan_NP Universal_NP Master_NP mix_NN and_CC the_DT ABI_NP Prism_NN 7700_CD sequence_NN detector_NN ._SENT Several_JJ dilutions_NNS of_IN cDNA_NN were_VBD tested_VBN to_TO construct_VB a_DT standard_JJ curve_NN that_WDT was_VBD used_VBN to_TO obtain_VB relative_JJ numbers_NNS for_IN the_DT samples_NNS ._SENT DI_NP particle_NN rescue_NN with_IN helper_NN virus_NN ._SENT |_SYM Dishes_NP of_IN BSR-T7_JJ cells_NNS (_( diameter_NN ,_, 9_CD cm_NN )_) were_VBD infected_VBN with_IN either_DT wild-type_NN SeV_NP (_( SeV-wt_NP )_) or_CC SeV-AGP55_NP at_IN an_DT MOI_NP of_IN 10_CD ._SENT One_CD hour_NN later_RBR ,_, the_DT medium_NN was_VBD removed_VBN and_CC the_DT cells_NNS were_VBD transfected_VBN with_IN 5_CD mug_NN of_IN the_DT DI-encoding_NP plasmid_NP ._SENT Twelve_CD hours_NNS later_RBR the_DT medium_NN was_VBD replaced_VBN with_IN fresh_JJ Dulbecco_NP 's_POS modified_JJ Eagle_NP medium_NN containing_VBG 10_CD %_NN fetal_JJ bovine_JJ serum_NN ._SENT The_DT ND_NN and_CC DI_NN particles_NNS present_JJ in_IN the_DT culture_NN medium_NN were_VBD then_RB passaged_VBN on_IN fresh_JJ cells_NNS as_RB described_VBD above_IN ._SENT DI_NP particle_NN rescue_NN with_IN plasmids_NNS ._SENT |_SYM Dishes_NP of_IN BSR-T7_JJ cells_NNS (_( diameter_NN ,_, 9_CD cm_NN )_) were_VBD transfected_VBN with_IN 1.5_CD mug_NN of_IN pGEM-L_NN ,_, 5_CD mug_NN of_IN pGEM-N_NN ,_, 5_CD mug_NN of_IN pGEM-PHA_NN (_( which_WDT does_VBZ not_RB express_VB C_NP proteins_NNS )_) ,_, and_CC 5_CD mug_NN of_IN the_DT various_JJ DI-encoding_NP plasmids_NNS ._SENT The_DT ratio_NN of_IN genomes_NNS to_TO antigenomes_NNS was_VBD previously_RB determined_VBN by_IN (32)P-primer_NN extension_NN analysis_NN ._SENT This_DT ratio_NN can_MD also_RB be_VB determined_VBN by_IN real-time_JJ reverse_JJ transcriptase_NN PCR_NP (_( RT-PCR_NP )_) analysis_NN ,_, as_RB follows_VBZ (_( and_CC as_RB described_VBN in_IN Materials_NPS and_CC Methods_NPS )_) ._SENT Four_CD pairs_NNS of_IN primers_NNS that_WDT span_VBP gene_NN junctions_NNS are_VBP used_VBN ;_: one_CD primer_NN of_IN each_DT pair_NN specifically_RB extends_VBZ on_IN genomes_NNS and_CC lies_VBZ upstream_RB of_IN the_DT junction_NN ,_, and_CC the_DT other_JJ specifically_RB extends_VBZ on_IN antigenomes_NNS and_CC lies_VBZ downstream_RB of_IN the_DT junction_NN ._SENT The_DT four_CD genome-specific_NN and_CC four_CD antigenome-specific_JJ primers_NNS are_VBP used_VBN in_IN individual_JJ reactions_NNS to_TO synthesize_VB cDNA_NN with_IN RT_NP ._SENT Samples_NNS of_IN the_DT RT_NP reaction_NN mixture_NN are_VBP then_RB used_VBN in_IN real-time_JJ PCR_NP amplification_NN along_IN with_IN the_DT reverse_JJ primer_NN located_VBN across_IN the_DT junction_NN ._SENT This_DT approach_NN eliminates_VBZ the_DT contribution_NN of_IN mRNAs_NNS to_TO the_DT amount_NN of_IN antigenomes_NNS determined_VBN (_( only_RB discistronic_JJ mRNAs_NNS that_WDT are_VBP very_RB rare_JJ in_IN SeV_NP infections_NNS will_MD be_VB scored_VBN )_) ._SENT At_IN least_JJS three_CD sets_NNS of_IN primers_NNS (_( and_CC fluorescent_JJ probes_NNS )_) were_VBD used_VBN for_IN each_DT determination_NN ,_, and_CC the_DT average_JJ genome/antigenome_NN ratio_NN from_IN at_IN least_JJS two_CD infections_NNS of_IN each_DT SeV_NP is_VBZ shown_VBN ._SENT The_DT ratios_NNS determined_VBN by_IN RT-PCR_NP agree_VBP well_RB with_IN those_DT determined_VBN by_IN primer_JJR extension_NN analysis_NN (_( in_IN parentheses_NNS in_IN Fig._NN )_) ,_, and_CC require_VB considerably_RB less_RBR viral_JJ RNA_NP as_IN starting_VBG material_NN ._SENT Relative_JJ to_TO SeV-wt_NP infections_NNS ,_, where_WRB ca_MD ._SENT 10_CD times_NNS as_IN many_JJ genomes_NNS as_IN antigenomes_NNS are_VBP found_VBN intracellularly_RB ,_, SeV-AGP55_NP infections_NNS (_( in_IN which_WDT the_DT entire_JJ 55_CD nt_NNS of_IN tr_NN is_VBZ replaced_VBN with_IN the_DT le_FW sequence_NN )_) contain_VBP equal_JJ levels_NNS of_IN the_DT two_CD ._SENT (_( AGP_NP refers_VBZ to_TO a_DT virus_NN or_CC DI_NN particle_NN ._SENT When_WRB "_`` AGP_NP "_'' is_VBZ followed_VBN by_IN a_DT single_JJ number_NN ,_, as_RB in_IN AGP55_NP ,_, this_DT indicates_VBZ that_IN positions_NNS 1_CD to_TO 55_CD of_IN AG/Pr_NP have_VBP been_VBN exchanged_VBN with_IN le_DT sequences_NNS ._SENT )_) SeV-AGP65_NP infections_NNS ,_, which_WDT contain_VBP gs-1_JJ in_IN addition_NN to_TO the_DT le_FW sequence_NN at_IN AG/Pr_NP ,_, yielded_VBD similar_JJ results_NNS ._SENT The_DT same_JJ genome-to-antigenome_NN ratios_NNS were_VBD found_VBN in_IN virions_NNS (_( data_NNS not_RB shown_VBN )_) ,_, since_RB ,_, similar_JJ to_TO rabies_NN virus_NN infections_NNS ,_, SeV_NP genomes_NNS are_VBP not_RB being_VBG selectively_RB exported_VBN during_IN virion_NN assembly_NN ._SENT Genome/antigenome_NN ratios_NNS intracellularly_RB should_MD then_RB simply_RB reflect_VB the_DT frequencies_NNS with_IN which_WDT vRdRP_NP productively_RB initiates_VBZ at_IN the_DT template_NN 3_CD '_'' ends_NNS and_CC begins_VBZ to_TO encapsidate_VB nascent_JJ le/tr_NN RNAs_NP ,_, to_TO produce_VB genome_NN or_CC antigenome_NN nucleocapsids_NNS ._SENT The_DT efficiency_NN of_IN this_DT process_NN is_VBZ one_CD measure_NN of_IN promoter_NN strength_NN ._SENT By_IN this_DT criterion_NN ,_, the_DT replacement_NN of_IN the_DT tr_NN region_NN of_IN AG/Pr_NP with_IN the_DT le_FW sequence_NN alone_RB (_( SeV-AGP55_NP )_) strongly_RB decreases_VBZ AG/Pr_NP strength_NN ._SENT Since_IN SeV-AGP55_NP replicates_VBZ to_TO levels_NNS similar_JJ to_TO those_DT of_IN SeV-wt_NP ,_, it_PP appears_VBZ that_IN G/Pr_NP is_VBZ inherently_RB weak_JJ only_RB in_IN the_DT presence_NN of_IN the_DT stronger_JJR AG/Pr_NN ._SENT Thus_RB ,_, as_IN described_VBN for_IN rabies_NN virus_NN infections_NNS ,_, competition_NN between_IN G/Pr_NP and_CC AG/Pr_NP for_IN vRdRP_NP appears_VBZ to_TO be_VB the_DT primary_JJ determinant_NN of_IN the_DT relative_JJ amounts_NNS of_IN SeV_NP genomes_NNS and_CC antigenomes_NNS formed_VBD The_DT genome/antigenome_NN ratio_NN of_IN 1_CD in_IN AGP55/65_NP infections_NNS suggests_VBZ that_IN promoter_NN strength_NN is_VBZ primarily_RB determined_VBN by_IN tr_NN versus_FW le_FW sequences_NNS themselves_PP ,_, in_IN agreement_NN with_IN previous_JJ studies_NNS of_IN DI_JJ genome_NN replication_NN ._SENT However_RB ,_, it_PP is_VBZ also_RB possible_JJ to_TO construct_VB SeV_NP in_IN which_WDT the_DT first_JJ 42_CD or_CC 48_CD nt_NNS of_IN the_DT le_FW sequence_NN of_IN G/Pr_NP is_VBZ replaced_VBN with_IN the_DT equivalent_JJ tr_NN sequences_NNS (_( SeV-GP42/48_NP )_) without_IN seriously_RB affecting_VBG viral_JJ mRNA_NN synthesis_NN ._SENT SeV-GP42_NP and_CC SeV-GP48_NP are_VBP notable_JJ in_IN that_IN their_PP$ infections_NNS fail_VBP to_TO induce_VB apoptosis_NN ._SENT Nevertheless_RB ,_, SeV-GP42/48_NP infections_NNS still_RB accumulate_VBP 10_CD times_NNS as_IN many_JJ genomes_NNS as_IN antigenomes_NNS intracellularly_RB ,_, like_IN SeV-wt_NP (_( only_RB SeV-GP42_NP is_VBZ shown_VBN in_IN Fig._NN )_) ._SENT This_DT result_NN was_VBD unexpected_JJ because_IN ,_, if_IN promoter_NN strength_NN is_VBZ determined_VBN primarily_RB by_IN the_DT nature_NN of_IN first_JJ 30_CD nt_NNS of_IN le/tr_NN sequence_NN ,_, the_DT modified_JJ G/Pr_NP of_IN SeV-GP42/48_NP should_MD have_VB been_VBN equivalent_JJ in_IN strength_NN to_TO AG/Pr_NP ._SENT Possible_JJ explanations_NNS for_IN why_WRB G/Pr_NP of_IN SeV-GP42/48_NP remains_VBZ weaker_JJR than_IN AG/Pr_NP include_VBP (_( i_NP )_) the_DT remainder_NN of_IN the_DT le_FW region_NN (_( positions_NNS 49_CD to_TO 55_CD )_) is_VBZ specifically_RB important_JJ for_IN G/Pr_NP strength_NN in_IN the_DT context_NN of_IN nondefective_JJ infections_NNS and_CC (_( ii_NNS )_) in_IN some_DT situations_NNS ,_, the_DT presence_NN of_IN gs-1_NN within_IN G/Pr_NP does_VBZ indeed_RB reduce_VB G/Pr_NP strength_NN ,_, despite_IN the_DT presence_NN of_IN 48_CD nt_NNS of_IN tr_NN sequence_NN ._SENT To_TO directly_RB examine_VB this_DT question_NN ,_, a_DT matched_VBN series_NN of_IN rSeV_NN isolates_NNS were_VBD prepared_VBN that_IN bridged_VBN the_DT transition_NN from_IN SeV-wt_NP to_TO SeV-AGP65_NP ._SENT Except_IN for_IN the_DT ambisense_NN SeV_NP (_( i.e._FW ,_, SeV_NP that_WDT expresses_VBZ ambisense_NN mRNA_NN )_) that_WDT grow_VBP less_RBR well_RB than_IN SeV-wt_NP ,_, all_PDT the_DT other_JJ SeV_NP grow_VB similarly_RB to_TO SeV-wt_NP ;_: i.e._FW ,_, they_PP all_RB accumulate_VBP similar_JJ levels_NNS of_IN viral_JJ macromolecules_NNS intracellularly_RB ._SENT SeV-wt+MCS_NP contains_VBZ a_DT cassette_NN at_IN the_DT L_NP gene_NN end/tr_NN junction_NN with_IN three_CD elements_NNS ,_, a_DT poly(A)-stop_NN site_NN that_WDT terminates_VBZ mRNAs_NNS transcribed_VBN from_IN the_DT antigenome_NP 3_CD '_POS end_NN ,_, a_DT multicloning_NN site_NN (_( MCS_NP )_) ,_, and_CC a_DT duplicated_VBN L_NP gene_NN end_NN site_NN ._SENT SeV-wt+MCS_NP infections_NNS produce_VBP genome/antigenome_NN ratios_NNS of_IN 10_CD like_IN SeV-wt_NP ;_: thus_RB ,_, the_DT inclusion_NN of_IN this_DT cassette_NN appears_VBZ not_RB to_TO have_VB affected_VBN relative_JJ promoter_NN strengths_NNS ._SENT SeV-AGP56-65_NP is_VBZ identical_JJ to_TO SeV-wt+MCS_NP except_IN that_WDT the_DT 10_CD nt_NNS adjacent_JJ to_TO tr_NN (_( i.e._FW ,_, the_DT L_NP gene_NN end_NN site_NN )_) are_VBP converted_VBN to_TO the_DT complement_NN of_IN gs-1_NN ._SENT Remarkably_RB ._SENT the_DT simple_JJ inclusion_NN of_IN these_DT 10_CD nt_NN (_( gs-1_JJ )_) in_IN AG/Pr_NP of_IN AGP56-65_NP leads_VBZ to_TO transcription_NN of_IN a_DT short_JJ (_( 80_CD nt_NN )_) ambisense_NN mRNA_NN from_IN this_DT antigenome_NN that_WDT terminates_VBZ just_RB before_IN the_DT opposing_JJ L_NP gene_NN ._SENT SeV-AGP56-65_JJ infections_NNS ,_, however_RB ,_, now_RB accumulate_VBP almost_RB as_IN many_JJ antigenomes_NNS as_IN genomes_NNS ._SENT Thus_RB ,_, gs-1_NN placed_VBN within_IN AG/Pr_NP not_RB only_RB functions_NNS well_RB but_CC also_RB apparently_RB acts_VBZ to_TO equalize_VB the_DT two_CD promoters_NNS ,_, presumably_RB by_IN weakening_VBG AG/Pr_NP ._SENT SeV-AGP52-65_NP and_CC AGP48-65_NP differ_VBP from_IN AGP56-65_NP by_IN the_DT further_JJR conversion_NN of_IN the_DT 4_CD and_CC 8_CD nt_NNS adjacent_JJ to_TO the_DT ambisense_NN gene_NN start_NN site_NN ._SENT The_DT exchange_NN of_IN these_DT nucleotides_NNS further_RBR increases_VBZ the_DT relative_JJ amounts_NNS of_IN antigenomes_NNS ,_, but_CC only_RB slightly_RB ._SENT Thus_RB ,_, AG/Pr_NP can_MD be_VB weakened_VBN relative_JJ to_TO G/Pr_NP in_IN one_CD of_IN two_CD ways_NNS :_: by_IN exchanging_VBG the_DT resident_JJ tr_NN sequences_NNS for_IN le_DT sequences_NNS or_CC by_IN introducing_VBG an_DT ectopic_JJ gs-1_NN within_IN this_DT 3'-end_JJ promoter_NN ._SENT The_DT introduction_NN of_IN gs-1_NN within_IN AG/Pr_NP automatically_RB destroys_VBZ the_DT L_NP gene_NN end_NN site_NN ._SENT It_PP thus_RB remains_VBZ possible_JJ that_IN the_DT destruction_NN of_IN this_DT sequence_NN is_VBZ responsible_JJ (_( at_IN least_JJS in_IN part_NN )_) for_IN weakening_VBG AG/Pr_NP ._SENT We_PP therefore_RB attempted_VBD to_TO prepare_VB derivatives_NNS of_IN wt+MCS_NNS in_IN which_WDT the_DT L_NP gene_NN end_NN site_NN is_VBZ mutated_VBN to_TO something_NN other_JJ than_IN the_DT complement_NN of_IN gs-1_NN ._SENT The_DT complement_NN of_IN the_DT L_NP gene_NN end_NN site_NN (_( 5_CD '_POS UAAGAAAAA_NP )_) was_VBD mutated_VBN to_TO 5_CD '_POS UGCCGCAUG_NP and_CC UUUCUUUUU_NP ._SENT However_RB ,_, we_PP were_VBD unable_JJ to_TO prepare_VB these_DT rSeV_NN in_IN three_CD separate_JJ attempts_NNS ,_, and_CC we_PP sought_VBD another_DT manner_NN to_TO examine_VB this_DT question_NN ._SENT The_DT mutated_VBN L_NP gene_NN end_NN sites_NNS were_VBD built_VBN into_IN mini-genomes_NNS expressing_VBG green_JJ fluorescent_JJ protein_NN (_( GFP_NP )_) ,_, and_CC these_DT were_VBD recovered_VBN from_IN DNA_NN by_IN coinfection_NN with_IN SeV-AGP55_NP (_( which_WDT contains_VBZ two_CD weak_JJ replication_NN promoters_NNS [_SYM see_VBP below_RB ]_SYM )_) ._SENT We_PP were_VBD again_RB unable_JJ to_TO recover_VB the_DT 5_CD '_POS UGCCGCAUG_NP mini-genome_NP (_( DI-Ge-1_NP ;_: replicable_JJ genomes_NNS may_MD not_RB tolerate_VB certain_JJ sequences_NNS here_RB )_) ._SENT However_RB ,_, DI-Ge-3_NP (_( 5_CD '_POS UUUCUUUUU_NN )_) could_MD be_VB recovered_VBN almost_RB as_RB well_RB as_IN the_DT wt_NN ._SENT When_WRB RNA_NP from_IN these_DT mixed_JJ infections_NNS were_VBD examined_VBN for_IN their_PP$ ratio_NN of_IN DI_JJ genomes_NNS to_TO antigenomes_NNS ,_, DI-Ge-3_NP and_CC DI-wt_NP were_VBD found_VBN to_TO contain_VB the_DT same_JJ excess_NN of_IN genomes_NNS over_IN antigenomes_NNS (_( approximately_RB threefold_RB in_IN this_DT case_NN ;_: the_DT ratio_NN of_IN DI_JJ genomes_NNS and_CC antigenomes_NNS are_VBP not_RB necessarily_RB the_DT same_JJ as_RB that_IN of_IN ND_NN genomes_NNS and_CC antigenomes_NNS )_) ._SENT Thus_RB ,_, the_DT loss_NN of_IN the_DT complement_NN of_IN the_DT L_NP gene_NN end_NN site_NN per_IN se_FW does_VBZ not_RB alter_VB AG/Pr_NP strength_NN ._SENT We_PP conclude_VBP that_IN it_PP is_VBZ the_DT presence_NN gs-1_NN within_IN AG/Pr_NP that_WDT is_VBZ responsible_JJ for_IN weakening_VBG this_DT 3'-end_JJ promoter_NN ._SENT Competition_NN between_IN DI_JJ genomes_NNS and_CC ND_NN helper_NN genomes_NNS for_IN vRdRP_NP ._SENT |_SYM The_DT relative_JJ amounts_NNS of_IN genomes_NNS and_CC antigenomes_NNS formed_VBN during_IN infection_NN is_VBZ one_CD measure_NN of_IN the_DT relative_JJ strengths_NNS of_IN G/Pr_NP and_CC AG/Pr_NP of_IN nondefective_JJ SeV_NP ._SENT This_DT manner_NN of_IN characterizing_VBG promoters_NNS stems_VBZ from_IN early_JJ studies_NNS of_IN copy_NN back_RB DI_JJ genomes_NNS ,_, which_WDT have_VBP deleted_VBN most_JJS of_IN the_DT genome_NN and_CC simultaneously_RB exchanged_VBD >96_JJ nt_NN of_IN G/Pr_NP with_IN the_DT equivalent_JJ sequences_NNS of_IN AG/Pr_NP ._SENT Copy_VB back_RB DI_JJ genomes_NNS do_VBP not_RB transcribe_VB mRNAs_NNS and_CC have_VBP a_DT clear_JJ replicative_JJ advantage_NN over_IN ND_NN virus_NN ._SENT Moreover_RB ,_, in_IN contrast_NN to_TO their_PP$ ND_NN helper_NN virus_NN ,_, these_DT coinfections_NNS accumulate_VBP equal_JJ amounts_NNS of_IN copy_NN back_RB DI_JJ genomes_NNS and_CC antigenomes_NNS ._SENT Further_JJR studies_NNS suggested_VBD that_IN their_PP$ replicative_JJ advantage_NN did_VBD not_RB stem_VB from_IN their_PP$ shorter_JJR length_NN ,_, and_CC that_DT relative_JJ promoter_NN strength_NN is_VBZ determined_VBN by_IN the_DT terminal_JJ 96_CD nt_NNS of_IN G/Pr_NP and_CC AG/Pr_NP ._SENT Internal-deletion_NP (_( int-Delta_NP )_) DIs_NP that_WDT maintain_VBP the_DT wt_JJ promoter_NN constellation_NN can_MD also_RB be_VB generated_VBN on_IN high-MOI_NN passage_NN of_IN SeV_NP stocks_NNS ._SENT However_RB ,_, these_DT DIs_NP are_VBP considerably_RB more_RBR difficult_JJ to_TO generate_VB ,_, and_CC the_DT reasons_NNS for_IN their_PP$ replicative_JJ advantage_NN over_IN their_PP$ ND_NN helper_NN virus_NN are_VBP unknown_JJ ._SENT In_IN further_JJR contrast_NN to_TO copy_VB back_RB DIs_NP ,_, int-Delta_NP DI_NP genomes_NNS cannot_MD be_VB recovered_VBN from_IN DNA_NN using_VBG SeV-wt_NP as_IN helper_NN ,_, even_RB though_IN they_PP are_VBP efficiently_RB amplified_VBN when_WRB the_DT replication_NN substrates_NNS (_( N_NP ,_, P_NN ,_, and_CC L_NP )_) are_VBP provided_VBN from_IN plasmids_NNS ._SENT More_RBR importantly_RB ,_, the_DT same_JJ int-Delta_NP DIs_NP are_VBP efficiently_RB recovered_VBN from_IN DNA_NN using_VBG SeV-AGP55_NP or_CC AGP65_NP as_IN helper_NN virus_NN (_( Fig._NN and_CC )_) ._SENT Thus_RB ,_, although_IN int-Delta_NP DIs_NP presumably_RB have_VBP no_DT advantage_NN in_IN competing_VBG with_IN wt_JJ helper_NN virus_NN for_IN limiting_VBG RdRP_NP during_IN recovery_NN from_IN DNA_NP ,_, int-Delta_NP DIs_NP can_MD clearly_RB compete_VB with_IN ND_NN helpers_NNS whose_WP$ AG/Pr_NN is_VBZ weakened_JJ (_( as_RB defined_VBN by_IN ND_NN genome/antigenome_NN ratios_NNS )_) ._SENT We_PP have_VBP adapted_VBN this_DT system_NN to_TO study_VB promoter_NN strength_NN by_IN including_VBG a_DT GFP_NP transcription_NN unit_NN within_IN int-Delta_NP DIs_NP ._SENT BSR_NP T7_JJ cells_NNS infected_VBN with_IN various_JJ helper_NN viruses_NNS are_VBP transfected_VBN with_IN plasmids_NNS expressing_VBG various_JJ mini-antigenomes_NNS (_( see_VB time_NN line_NN in_IN Fig._NN )_) ._SENT The_DT particles_NNS released_VBD 36_CD to_TO 48_CD h_NN postinfection_NN are_VBP then_RB used_VBN to_TO infect_VB fresh_JJ cultures_NNS that_WDT are_VBP examined_VBN by_IN fluorescent_JJ microscopy_NN for_IN GFP_NP expression_NN ._SENT This_DT simple_JJ test_NN reveals_VBZ whether_IN the_DT DI_JJ particles_NNS have_VBP been_VBN generated_VBN from_IN plasmid_NP DNA_NP during_IN the_DT initial_JJ infection/transfection_NN ,_, and_CC amplified_VBN by_IN the_DT helper_NN virus_NN during_IN subsequent_JJ coinfection_NN (_( P1_NP )_) ._SENT Using_VBG this_DT DI_JJ reporter_NN system_NN ,_, we_PP have_VBP reexamined_VBN whether_IN gs-1_NN within_IN G/Pr_NP affects_VBZ the_DT ability_NN of_IN G/Pr_NP to_TO compete_VB for_IN vRdRP_NP during_IN coinfection_NN ._SENT A_DT series_NN of_IN mini-genome_NN constructs_NNS that_WDT varied_VBD only_RB in_IN their_PP$ G/Pr_NP was_VBD used_VBN to_TO determine_VB what_WP changes_NNS were_VBD required_VBN so_RB that_IN the_DT int-Delta_NN DI_NN could_MD be_VB recovered_VBN and_CC amplified_VBN by_IN SeV-wt_NP helper_NN (_( 5_CD top_JJ constructs_NNS ,_, Fig._NN )_) ._SENT We_PP first_RB exchanged_VBD the_DT first_JJ 42_CD or_CC 55_CD nt_NNS of_IN le_DT of_IN G/Pr_NP with_IN the_DT equivalent_JJ tr_NN sequences_NNS (_( GP42/wt_NP and_CC GP55/wt_NP )_) ,_, but_CC only_RB background_NN fluorescence_NN was_VBD found_VBN at_IN passage_NN 1_CD ._SENT We_PP then_RB added_VBD a_DT further_JJR 12_CD nt_NN of_IN the_DT trailer_NN sequence_NN but_CC maintained_VBD the_DT remainder_NN of_IN DI_NP GP55/wt_NP ,_, so_RB that_IN the_DT GFP_NP expression_NN was_VBD retained_VBN and_CC now_RB started_VBD at_IN nt_RB 68_CD rather_RB than_IN nt_NN 56_CD (_( DI_NP GP68+start/wt_NP )_) ._SENT However_RB ,_, this_DT DI_NN as_RB well_RB could_MD not_RB be_VB recovered_VBN (_( in_IN six_CD attempts_NNS )_) with_IN SeV-wt_NP ._SENT Only_RB when_WRB the_DT mRNA_NN start_NN site_NN was_VBD eliminated_VBN from_IN G/Pr_NP of_IN DI_NP GP55/wt_NP ,_, by_IN exchanging_VBG it_PP for_IN the_DT equivalent_JJ AG/Pr_NP sequence_NN (_( DI_NP GP96/wt_NP )_) ,_, was_VBD this_DT DI_NN recovered_VBD with_IN SeV-wt_NP ._SENT (_( The_DT elimination_NN of_IN gs-1_NN of_IN course_NN also_RB eliminates_VBZ GFP_NP expression_NN ,_, and_CC DI_NP RNA_NP levels_NNS were_VBD determined_VBN by_IN real-time_JJ RT-PCR_NN [_SYM Fig._NN ,_, bottom_NN ]_SYM ._SENT )_) Thus_RB ,_, int-Delta_NP DI_NP genomes_NNS successfully_RB compete_VBP for_IN vRdRP_NP with_IN wt_JJ helper_NN genomes_NNS only_RB when_WRB the_DT mRNA_NN start_NN site_NN within_IN G/Pr_NP has_VBZ been_VBN eliminated_VBN ;_: simply_RB moving_VBG gs-1_JJ downstream_RB by_IN 12_CD nt_NNS (_( DI_NP 68+start/wt_NP )_) has_VBZ no_DT effect_NN ._SENT Similar_JJ experiments_NNS were_VBD carried_VBN out_RP with_IN DI_JJ wt/AGP55_NN ,_, which_WDT contains_VBZ le_DT in_IN place_NN of_IN tr_NN sequences_NNS at_IN AG/Pr_NP (_( bottom_NN three_CD constructs_NNS in_IN Fig._NN )_) ._SENT Just_RB as_IN DI-wt/wt_NP cannot_MD be_VB rescued_VBN by_IN coinfection_NN with_IN SeV-wt_NP ,_, DI_NN wt/AGP55_NN cannot_MD be_VB rescued_VBN by_IN coinfection_NN with_IN SeV-AGP55_NP (_( presumably_RB because_IN both_DT G/Pr_NP and_CC AG/Pr_NP of_IN the_DT DI_NP and_CC ND-helper_NP virus_NN are_VBP again_RB equivalent_JJ )_) ._SENT When_WRB the_DT first_JJ 42_CD nt_NNS of_IN G/Pr_NP are_VBP exchanged_VBN for_IN the_DT equivalent_JJ tr_NN sequences_NNS ,_, this_DT DI_NP GP42/AGP55_NP cannot_MD be_VB rescued_VBN by_IN SeV-AGP55_NP ._SENT However_RB ,_, DI_NP GP96/AGP55_NP ,_, in_IN which_WDT the_DT first_JJ 96_CD nt_NNS are_VBP trailer_NN sequence_NN and_CC gs-1_NN is_VBZ eliminated_VBN ,_, can_MD be_VB rescued_VBN with_IN SeV-AGP55_NP ._SENT Taken_VBN together_RB ,_, these_DT results_NNS indicate_VBP that_IN gs-1_JJ within_IN G/Pr_NP clearly_RB decreases_VBZ the_DT ability_NN of_IN this_DT 3'-end_JJ promoter_NN to_TO compete_VB for_IN vRdRP_NP during_IN recovery_NN from_IN DNA_NN with_IN helper_NN SeV_NP and_CC subsequent_JJ coinfection_NN ._SENT The_DT 96-nt_NP G/Pr_NP contains_VBZ 55_CD nt_NN of_IN le_DT sequence_NN (_( light_JJ color_NN ,_, weak_JJ )_) ,_, gs-1_JJ (_( oval_JJ with_IN arrow_NN )_) and_CC a_DT simple_JJ hexamer_NN repeat_NN (_( BB_NP box_NN )_) ,_, whereas_IN the_DT symmetrical_JJ AG/Pr_NP contains_VBZ tr_NN sequence_NN (_( dark_JJ color_NN ,_, strong_JJ )_) ,_, the_DT L_NP gene_NN end_NN site_NN (_( empty_JJ oval_NN )_) ,_, and_CC a_DT BB_NP box_NN ._SENT AG/Pr_NP is_VBZ a_DT stronger_JJR replication_NN promoter_NN than_IN G/Pr_NP ,_, as_RB defined_VBN by_IN the_DT preponderance_NN of_IN genomes_NNS formed_VBN during_IN virus_NN replication_NN ._SENT In_IN these_DT and_CC other_JJ experiments_NNS ,_, the_DT two_CD BB_NP boxes_NNS appear_VBP to_TO be_VB interchangeable_JJ without_IN effect_NN (_( data_NNS not_RB shown_VBN )_) ._SENT The_DT major_JJ finding_NN of_IN this_DT work_NN is_VBZ that_IN gs-1_JJ within_IN 3'-end_JJ promoters_NNS negatively_RB influences_VBZ promoter_NN strength_NN ._SENT Our_PP$ results_NNS are_VBP summarized_VBN schematically_RB in_IN Fig._NN ._SENT G/Pr_NP contains_VBZ two_CD elements_NNS that_WDT weaken_VBP this_DT 3'-end_JJ promoter_NN relative_JJ to_TO AG/Pr_NP ;_: the_DT presence_NN of_IN the_DT le_FW as_IN opposed_VBN to_TO the_DT tr_NN sequences_NNS ,_, and_CC gs-1_JJ ._SENT Simply_RB replacing_VBG the_DT tr_NN sequence_NN of_IN AG/Pr_NP with_IN le_DT sequence_NN reduces_VBZ AG/Pr_NP strength_NN such_JJ that_IN SeV-AGP55_NP infections_NNS now_RB accumulate_VBP equal_JJ amounts_NNS of_IN genomes_NNS and_CC antigenomes_NNS ._SENT Similarly_RB ,_, introducing_VBG gs-1_JJ into_IN AG/Pr_NP of_IN SeV-wt+MCS_NP (_( SeV-AGP56-65_NP )_) reduces_VBZ the_DT genome/antigenome_NN ratio_NN from_IN 12_CD to_TO 2.5_CD ._SENT Thus_RB ,_, the_DT stronger_JJR AG/Pr_NN apparently_RB can_MD be_VB weakened_VBN in_IN two_CD different_JJ ways_NNS ._SENT G/Pr_NP has_VBZ been_VBN examined_VBN via_IN DI_JJ mini-genomes_NNS as_RB well_RB as_IN ND-SeV_NP ,_, because_IN gs-1_NN is_VBZ not_RB essential_JJ for_IN DI-genome_NP replication_NN ._SENT Exchanging_VBG the_DT first_JJ 42_CD or_CC 48_CD nt_NNS of_IN the_DT le_FW region_NN of_IN G/Pr_NP of_IN ND_NN viruses_NNS with_IN the_DT equivalent_JJ tr_NN sequences_NNS (_( SeV-GP42/48_NP )_) does_VBZ not_RB diminish_VB the_DT genome/antigenome_NN ratio_NN of_IN 10_CD ,_, nor_CC does_VBZ the_DT analogous_JJ exchange_NN of_IN the_DT first_JJ 55_CD nt_NNS of_IN G/Pr_NP improve_VB the_DT ability_NN of_IN int-Delta_NP DI_NP genomes_NNS to_TO be_VB rescued_VBN by_IN SeV-wt_NP ._SENT Thus_RB ,_, simply_RB exchanging_VBG le_DT for_IN tr_NN sequences_NNS apparently_RB cannot_MD overcome_VB the_DT negative_JJ effects_NNS of_IN gs-1_NN within_IN G/Pr_NP ._SENT The_DT simultaneous_JJ elimination_NN of_IN the_DT mRNA_NN start_NN site_NN within_IN G/Pr_NP of_IN int-Delta_NP DI_NP genomes_NNS (_( DI_NP GP98/wt_NP and_CC DI_NP GP98/AGP55_NP )_) was_VBD found_VBN to_TO be_VB essential_JJ for_IN their_PP$ rescue_NN by_IN SeV-wt_NP and_CC SeV-AGP55_NP ,_, respectively_RB ._SENT Thus_RB ,_, the_DT ability_NN of_IN DI_JJ genomes_NNS to_TO compete_VB with_IN helper_NN virus_NN genomes_NNS for_IN vRdRP_NP is_VBZ dominated_VBN by_IN the_DT presence_NN of_IN gs-1_NN within_IN the_DT DI_JJ genome_NN ._SENT We_PP note_VBP that_IN there_EX are_VBP also_RB examples_NNS at_IN AG/Pr_NP where_WRB the_DT converse_JJ situations_NNS applies_VBZ ,_, namely_RB ,_, where_WRB the_DT presence_NN of_IN le_DT as_RB opposed_VBN to_TO the_DT tr_NN sequences_NNS predominates_VBZ ,_, and_CC effects_NNS due_JJ to_TO the_DT presence_NN of_IN gs-1_JJ are_VBP not_RB detected_VBN (_( e.g._FW ,_, SeV-AGP55_NP and_CC SeV-AGP65_NP rescue_NN int-Delta_NN DI_NN genomes_NNS with_IN equal_JJ efficiency_NN )_) ._SENT Almost_RB all_PDT our_PP$ DI_NN constructs_NNS were_VBD efficiently_RB amplified_VBN when_WRB their_PP$ replication_NN substrates_NNS were_VBD provided_VBN via_IN plasmids_NNS (_( in_IN the_DT absence_NN of_IN other_JJ competing_JJ SeV_NP templates_NNS )_) ._SENT The_DT inability_NN of_IN some_DT constructs_NNS to_TO be_VB rescued_VBN with_IN SeV-wt_NP ,_, coupled_VBN with_IN their_PP$ efficient_JJ rescue_NN with_IN SeV-AGP55/65_NP ,_, suggests_VBZ that_IN DI_NN rescue_NN depends_VBZ on_IN the_DT ability_NN of_IN the_DT DI_JJ 3'-end_JJ promoters_NNS to_TO compete_VB with_IN the_DT helper_NN genomes_NNS for_IN vRdRP_NP ._SENT It_PP is_VBZ from_IN these_DT experiments_NNS that_IN the_DT conclusion_NN that_IN gs-1_NN negatively_RB affects_VBZ 3'-end_JJ promoter_NN strength_NN comes_VBZ through_IN most_JJS clearly_RB ._SENT On_IN what_WP basis_NN ,_, though_RB ,_, does_VBZ gs-1_JJ within_IN G/Pr_NP diminish_VBP the_DT ability_NN of_IN DI_JJ genomes_NNS to_TO compete_VB with_IN ND_NN genomes_NNS for_IN replication_NN substrates_NNS ?_SENT Simple_JJ competition_NN of_IN resting_JJ ND_NN and_CC DI_NP N:RNAs_NP for_IN a_DT common_JJ pool_NN of_IN vRdRP_NP (_( off_IN the_DT template_NN )_) may_MD be_VB part_NN of_IN the_DT explanation_NN ._SENT In_IN this_DT case_NN ,_, the_DT competition_NN implies_VBZ that_IN the_DT eventual_JJ transcriptases_NNS and_CC replicases_NNS cannot_MD be_VB distinguished_VBN off_RP the_DT template_NN ._SENT However_RB ,_, it_PP is_VBZ also_RB possible_JJ that_IN this_DT competition_NN occurs_VBZ in_IN cis_NNS ,_, once_RB vRdRP_NP has_VBZ engaged_VBN G/Pr_NP ,_, as_IN this_DT might_MD offer_VB an_DT explanation_NN for_IN why_WRB the_DT presence_NN of_IN gs-1_NN within_IN G/Pr_NP is_VBZ so_RB deleterious_JJ for_IN 3'-end_JJ promoter_NN strength_NN ._SENT A_DT model_NN for_IN this_DT in-cis_NN competition_NN is_VBZ shown_VBN in_IN Fig._NN ._SENT vRdRP_NP in_IN this_DT cartoon_NN (_( elongated_VBN oval_NN )_) has_VBZ already_RB initiated_VBN at_IN the_DT genome_NN 3_CD '_'' end_NN and_CC cleared_VBD the_DT promoter_NN ._SENT In_IN those_DT cases_NNS where_WRB RNA_NP synthesis_NN and_CC assembly_NN with_IN N_NP become_VBP coupled_VBN ,_, vRdRP_NP is_VBZ committed_VBN to_TO replication_NN and_CC this_DT P4-L_NP does_VBZ not_RB reenter_VB the_DT pool_NN until_IN it_PP has_VBZ completed_VBN N:RNA_NP synthesis_NN ._SENT G/Pr_NN strength_NN ,_, or_CC its_PP$ relative_JJ ability_NN to_TO initiate_VB RNAs_NNS that_WDT are_VBP subsequently_RB coassembled_VBN with_IN N_NP ,_, is_VBZ presumably_RB conditioned_VBN by_IN the_DT presence_NN of_IN the_DT le_FW versus_FW tr_NN sequences_NNS within_IN G/Pr_NP ._SENT These_DT sequences_NNS as_IN genome_NN would_MD promote_VB vRdRP_NP initiation_NN ,_, and_CC as_RB nascent_JJ [_SYM +_SYM ]_SYM le_FW RNA_NP would_MD promote_VB N_NP assembly_NN ._SENT When_WRB RNA_NP synthesis_NN and_CC its_PP$ assembly_NN with_IN N_NP do_VBP not_RB become_VB coupled_VBN ,_, vRdRP_NP releases_VBZ the_DT nascent_JJ le_FW chain_NN at_IN or_CC near_IN gs-1_NN ._SENT If_IN vRdRP_NP is_VBZ simultaneously_RB released_VBN from_IN the_DT template_NN along_IN with_IN the_DT le_FW RNA_NP ,_, this_DT P4-L_NP rejoins_VBZ the_DT vRdRP_NP pool_NN off_IN the_DT template_NN and_CC is_VBZ free_JJ to_TO interact_VB with_IN all_PDT the_DT available_JJ 3'-end_JJ promoters_NNS in_IN the_DT coinfected_JJ cell_NN ._SENT However_RB ,_, if_IN vRdRP_NP is_VBZ not_RB released_VBN from_IN the_DT template_NN along_IN with_IN le_DT RNA_NP ,_, it_PP may_MD then_RB be_VB free_JJ to_TO scan_VB the_DT template_NN (_( in_IN both_DT directions_NNS )_) for_IN the_DT nearby_JJ gs-1_NN as_RB well_RB as_IN the_DT genome_NN 3_CD '_'' end_NN ,_, similar_JJ to_TO vRdRP_NP that_WDT has_VBZ released_VBN its_PP$ mRNA_NN at_IN gene_NN junctions_NNS ._SENT Scanning_VBG confers_VBZ an_DT advantage_NN to_TO this_DT 3'-end_JJ promoter_NN ,_, precisely_RB because_IN vRdRP_NP is_VBZ restricted_VBN to_TO reinitiating_VBG on_IN this_DT template_NN ._SENT The_DT presence_NN of_IN gs-1_NN within_IN G/Pr_NP weakens_VBZ this_DT replication_NN promoter_NN by_IN diverting_VBG these_DT scanning_VBG vRdRP_NN from_IN reinitiating_VBG at_IN the_DT genome_NN 3_CD '_'' end_NN ,_, thus_RB decreasing_VBG its_PP$ relative_JJ replication_NN promoter_NN strength_NN ._SENT A_DT corollary_NN of_IN this_DT competition-in-cis_NN model_NN is_VBZ that_IN relative_JJ initiation_NN from_IN gs-1_NN will_MD similarly_RB depend_VB on_IN competition_NN with_IN the_DT 3'-end_JJ promoter_NN ;_: i.e._FW ,_, gs-1_NN will_MD be_VB initiated_VBN more_RBR frequently_RB when_WRB present_JJ within_IN or_CC near_IN G/Pr_NP (_( near_RB weaker_JJR le_DT sequence_NN )_) than_IN within_IN or_CC near_IN AG/Pr_NP (_( near_IN stronger_JJR tr_NN sequence_NN )_) ._SENT This_DT aspect_NN has_VBZ recently_RB been_VBN tested_VBN with_IN DI_JJ mini-genomes_NNS containing_VBG tandem_JJ 96-nt_NN promoters_NNS in_IN which_WDT gs-1_JJ of_IN the_DT external_JJ promoter_NN was_VBD corrupted_VBN and_CC the_DT replicative_JJ ability_NN of_IN the_DT internal_JJ promoter_NN was_VBD disabled_VBN ,_, such_PDT that_DT gs-1_NN of_IN the_DT internal_JJ promoter_NN was_VBD now_RB found_VBN at_IN position_NN 146_CD ,_, i.e._FW ,_, 50_CD nt_NNS downstream_JJ of_IN the_DT external_JJ 96-nt_NN replication_NN promoter_NN ._SENT In_IN this_DT location_NN ,_, gs-1_NN was_VBD used_VBN 15_CD times_NNS more_RBR frequently_RB when_WRB downstream_JJ of_IN a_DT weak_JJ G/Pr_NN than_IN downstream_JJ of_IN a_DT strong_JJ AG/Pr_NP (_( D._NP Vulliemoz_NP ,_, P._NP Le_NP Mercier_NP ,_, and_CC L._NP Roux_NP ,_, personal_JJ communication_NN )_) ._SENT Again_RB ,_, the_DT obvious_JJ conclusion_NN is_VBZ that_IN gs-1_JJ and_CC nearby_JJ replication_NN promoters_NNS compete_VBP with_IN each_DT other_JJ ,_, presumably_RB in_IN cis_NNS ,_, for_IN a_DT common_JJ pool_NN of_IN vRdRP_NP in_IN coinfected_JJ cells_NNS ._SENT Genome_NN 3'-end_JJ promoter_NN (_( G/Pr_NP )_) in_IN resting_JJ nucleocapsids_NNS ._SENT Genome_NN 3'-end_JJ promoter_NN (_( G/Pr_NP )_) in_IN resting_JJ nucleocapsids_NNS ._SENT A_DT model_NN of_IN the_DT helical_JJ N-subunit_NP assembly_NN of_IN the_DT SeV_NP resting_JJ genome_NN nucleocapsid_NN is_VBZ shown_VBN ,_, based_VBN on_IN the_DT electron_NN micrographic_JJ reconstruction_NN of_IN Egelman_NP et_FW al._FW ,_, with_IN a_DT pitch_NN of_IN 5.3_CD nm_NN and_CC 13_CD subunits_NN per_IN turn_NN ._SENT The_DT position_NN of_IN the_DT genome_NN RNA_NP within_IN this_DT structure_NN is_VBZ unknown_JJ ;_: the_DT RNA_NP line_NN is_VBZ placed_VBN on_IN the_DT outside_JJ surface_NN of_IN the_DT N_NP assembly_NN for_IN clarity_NN and_CC because_IN it_PP is_VBZ just_RB long_JJ enough_RB when_WRB extended_VBN to_TO occupy_VB this_DT position_NN ._SENT The_DT N_NP subunits_NN (_( and_CC the_DT 6_CD nt_JJ positions_NNS within_IN each_DT subunit_NN )_) are_VBP numbered_VBN from_IN the_DT genome_NN 3_CD '_'' end_NN (_( lower_JJR right_NN )_) ._SENT An_DT enlargement_NN of_IN the_DT bipartite_JJ 3'-end_JJ promoter_NN (_( dark_JJ subunits_NN on_IN the_DT left_NN )_) is_VBZ shown_VBN on_IN the_DT right_NN ,_, where_WRB the_DT 3'-terminal_JJ 96_CD nt_NNS are_VBP placed_VBN within_IN each_DT subunit_NN in_IN groups_NNS of_IN six_CD ._SENT The_DT 3'-terminal_JJ 12_CD nt_NNS and_CC the_DT [_SYM C1N2N3N4N5N6]3_JJ repeat_NN conserved_VBN in_IN all_DT genomes_NNS and_CC antigenomes_NNS of_IN respiro-and_NN morbilliviruses_NNS are_VBP highlighted_VBN ._SENT The_DT position_NN of_IN the_DT N_NP gene_NN start_NN site_NN (_( gs-1_JJ )_) is_VBZ also_RB indicated_VBN ._SENT 3'-end_JJ promoter_NN mutations_NNS of_IN nondefective_JJ SeV_NP and_CC the_DT ratio_NN of_IN genomes_NNS to_TO antigenomes_NNS formed_VBN during_IN infection_NN ._SENT 3'-end_JJ promoter_NN mutations_NNS of_IN nondefective_JJ SeV_NP and_CC the_DT ratio_NN of_IN genomes_NNS to_TO antigenomes_NNS formed_VBN during_IN infection_NN ._SENT (_( A_NP )_) The_DT SeV_NP genomes_NNS are_VBP shown_VBN as_IN a_DT series_NN of_IN boxes_NNS (_( not_RB drawn_VBN to_TO scale_VB )_) ._SENT (_( B_LS )_) The_DT 96-nt_NN genome_NN 3'-end_JJ promoter_NN (_( on_IN the_DT left_NN )_) and_CC antigenome_JJ 3'-end_JJ promoter_NN (_( right_JJ )_) are_VBP shown_VBN as_IN narrow_JJ boxes_NNS ._SENT The_DT remainder_NN of_IN the_DT genome_NN (_( from_IN the_DT N_NP gene_NN AUG_NP codon_NN to_TO the_DT UAA_NP that_WDT terminates_VBZ the_DT L_NP open_JJ reading_NN frame_NN )_) is_VBZ shown_VBN as_IN wider_JJR boxes_NNS ._SENT The_DT genome_NN and_CC antigenome_JJ 3'-end_JJ promoters_NNS ,_, G/Pr_NP and_CC AG/Pr_NP ,_, are_VBP composed_VBN ,_, respectively_RB ,_, of_IN 55_CD nt_NNS of_IN le_FW (_( white_JJ box_NN )_) or_CC tr_NN sequence_NN (_( black_JJ box_NN )_) ,_, gs-1_JJ (_( white_JJ circle_NN with_IN forward_JJ arrow_NN )_) or_CC the_DT complement_NN of_IN the_DT L_NP gene_NN end_NN signal_NN (_( black_JJ circle_NN with_IN stopped_VBN arrow_NN )_) ,_, a_DT short_JJ spacer_NN sequence_NN ,_, and_CC the_DT [_SYM C1N2N3N4N5N6]3_JJ repeat_NN or_CC its_PP$ complement_NN (_( BB_NP box_NN )_) ._SENT The_DT cassettes_NNS added_VBD at_IN the_DT L_NP gene_NN end/tr_NN junction_NN to_TO control_VB ambisense_NN mRNA_NN expression_NN are_VBP marked_VBN with_IN a_DT dotted_JJ line_NN ._SENT White_JJ and_CC grey_JJ indicate_VBP the_DT various_JJ G/Pr_NP and_CC AG/Pr_NP sequences_NNS present_JJ at_IN each_DT 3'-end_JJ promoter_NN ._SENT In_IN naming_VBG the_DT viruses_NNS ,_, GP_NN and_CC its_PP$ associated_JJ numbers_NNS refer_VBP to_TO those_DT nucleotides_NNS of_IN G/Pr_NP that_WDT have_VBP been_VBN replaced_VBN with_IN the_DT equivalent_JJ sequences_NNS of_IN AG/Pr_NP ,_, or_CC vice_JJ versa_RB for_IN AGP_NP viruses_NNS ._SENT Total_NP RNA_NP from_IN cytoplasmic_JJ extracts_VBZ of_IN A549_NP cells_NNS infected_VBN for_IN 24_CD h_NN with_IN 20_CD PFU/cell_NN of_IN the_DT various_JJ ND-SeV_NP was_VBD used_VBN to_TO estimate_VB the_DT relative_JJ amounts_NNS of_IN genomes_NNS and_CC antigenomes_NNS by_IN real-time_JJ RT-PCR_NP ._SENT Four_CD sets_NNS of_IN primers_NNS and_CC probes_NNS that_WDT spanned_VBD different_JJ gene_NN junctions_NNS (_( A_NP )_) were_VBD used_VBN (_( to_TO minimize_VB the_DT contribution_NN of_IN mRNA_NN to_TO the_DT antigenome_JJ determination_NN [_SYM see_VB Materials_NNS and_CC Methods_NNS ]_SYM )_) ._SENT At_IN least_JJS three_CD sets_NNS of_IN primers_NNS and_CC probes_NNS were_VBD used_VBN for_IN each_DT determination_NN ,_, and_CC the_DT average_JJ G/AG_NP ratio_NN from_IN at_IN least_JJS two_CD infections_NNS of_IN each_DT SeV_NP is_VBZ shown_VBN ._SENT The_DT numbers_NNS in_IN parentheses_NNS show_VBP the_DT ratios_NNS determined_VBN by_IN 32P-labeled_JJ primer_NN extension_NN ._SENT Defective-interfering_NP mini-genomes_NNS expressing_VBG GFP_NP ._SENT Defective-interfering_NP mini-genomes_NNS expressing_VBG GFP_NP ._SENT (_( A_NP )_) DI-wt_NP ,_, in_IN which_WDT the_DT entire_JJ viral_JJ coding_VBG sequences_NNS (_( from_IN the_DT N_NP gene_NN AUG_NN to_TO the_DT UAA_NP of_IN the_DT L_NP open_JJ reading_NN frame_NN )_) were_VBD replaced_VBN with_IN the_DT GFP_NP open_JJ reading_NN frame_NN ,_, is_VBZ shown_VBN schematically_RB as_RB for_IN Fig._NN ._SENT The_DT sequences_NNS present_JJ at_IN L_NP gene_NN end_NN site_NN of_IN DI-wt_NP ,_, DI-Ge-1_NP and_CC DI-Ge-3_NP (_( see_NN text_NN )_) are_VBP indicated_VBN ._SENT (_( B_LS )_) A_DT time_NN line_NN of_IN DI_JJ particle_NN recovery_NN from_IN DNA_NP is_VBZ shown_VBN (_( see_VB text_NN for_IN details_NNS )_) ._SENT Green_JJ fluorescent_JJ photos_NNS of_IN the_DT first_JJ passage_NN cultures_NNS (_( P1_NP )_) that_WDT contained_VBD equal_JJ densities_NNS of_IN cells_NNS are_VBP shown_VBN ._SENT To_TO measure_VB viral_JJ RNA_NP levels_NNS ,_, two_CD additional_JJ virus_NN passages_NNS were_VBD carried_VBN out_RP to_TO minimize_VB spill-over_NN from_IN biased_VBN genome/antigenome_NN ratios_NNS during_IN DI_JJ recovery_NN from_IN DNA_NP ._SENT Genome/antigenome_NP levels_NNS were_VBD then_RB determined_VBN by_IN real-time_JJ RT-PCR_NP with_IN the_DT two_CD primers_NNS pairs_NNS and_CC probe_NN as_RB indicated_VBD in_IN panel_NN A._NP Transfection_NP of_IN DI-wt_NP without_IN helper_NN virus_NN (_( first_JJ photo_NN in_IN panel_NN A_DT )_) ,_, and_CC DI-Ge-1_JJ transfection_NN with_IN helper_NN virus_NN (_( third_JJ photo_NN in_IN panel_NN A_DT )_) serve_VB as_IN negative_JJ controls_NNS that_WDT show_VBP the_DT amplification_NN specificity_NN for_IN the_DT DI_NP RNAs_NP ._SENT Error_NN bars_NNS ,_, standard_JJ deviations_NNS ._SENT DI_NP particle_NN recovery_NN from_IN DNA_NN with_IN various_JJ nondefective_JJ helper_NN SeV_NP ._SENT DI_NP particle_NN recovery_NN from_IN DNA_NN with_IN various_JJ nondefective_JJ helper_NN SeV_NP ._SENT The_DT various_JJ DI_NN constructs_NNS are_VBP shown_VBN schematically_RB and_CC are_VBP named_VBN as_RB for_IN Fig._NN and_CC ._SENT For_IN those_DT constructs_NNS with_IN a_DT functional_JJ gs-1_NN driving_VBG GFP_NP expression_NN ,_, recovery_NN was_VBD scored_VBN (_( +_SYM or_CC -_: )_) by_IN flu_NN 